Retatrutide Pen – 30mg

Retatrutide Pen 30mg — Research Overview

The Retatrutide Pen 30mg contains the same advanced multi-agonist peptide as standard retatrutide, prepared in a controlled, pre-measured delivery format for use in laboratory and institutional research settings. This format is designed to support consistent compound handling, accuracy and reproducibility across metabolic and endocrine research protocols. This compound is supplied by ReGen-X exclusively for scientific and laboratory research.

Mechanism of Action (Research Context)
Retatrutide is studied for its activity at three metabolic signalling receptors:

• GLP-1 receptor — associated with glucose regulation and appetite signalling
• GIP receptor — involved in insulin and lipid metabolism
• Glucagon receptor — linked to energy expenditure and fat mobilisation

The combined signalling profile allows researchers to study how multiple metabolic pathways interact in complex biological models.

Research Summary
In laboratory models, retatrutide has been investigated for its potential role in:

• Energy balance regulation
• Insulin signalling and glucose transport
• Lipid metabolism and fat oxidation
• Appetite-related biochemical pathways

Browse our full range of Metabolic & GLP-1 research compounds.

Product Specifications

• Compound: Retatrutide Pen 30mg
• Quantity: 30mg (pre-formulated)
• Format: Research pen delivery system
• Intended for: Controlled laboratory research environments
• Storage: Refrigerated per laboratory peptide handling standards

Important Research Use Notice
This product is sold strictly for laboratory and scientific research use only. It is not a medicine, not a supplement, and not approved for human or veterinary use. No medical, therapeutic, or health claims are made or implied.